Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 203.50

-1.6%

Nov 25 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (27771)	2/3/1999 8:44:00 AM
From: Alper H.YUKSEL	Read Replies (2) of 32384

Henry, Contrary to what some on the thread were arguing, the FDA approval was a foregone conclusion (panel review of 7-1 ?), only the timing was the real issue. For this reason, I don't believe that this will have an effect on the price. The market has already priced the approval of Panretin and Ontak in my view, when LGND appreciated from $5 and change to $12 in the last 5 months. We may even see a dip later in the day, which should be a viewed as a good opportunity to buy some more. From now on, news on Targretin and sales pace of Panretin (to some extent thought) will be the price drivers. FWIW Regards Alper

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next